While some studies postulated that BCL11B acted as a tumor suppressor and that inactivating mutations played a role in tumor development [13,14], others, including our studies, suggested BCL11B as being an oncogene [6,15] and its downregulation resulting in apoptosis of malignant T cells. This evidence concerns the gene BCL11B and neoplasm.